Intra-tumor injection of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX2 carcinoma of the tongue

International Journal of Oral and Maxillofacial Surgery

Volumn 28, Issue 2, 1999, Pages 118-124

  Matsumoto, Kentaro ^a   Ninomiya, Yasuro ^a   Inoue, Masaki ^a   Tomioka, Tokuya ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Angiogenesis inhibitor; Carcinoma of the tongue; Microvessel density; PCNA

Indexed keywords

EID: 0033114830     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0020.1999.282280205.x     Document Type: Article

References (25)

1. ABE T, OKAMURA K, ONO M, et al. Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis. J Clin Invest 1993: 92: 54-61.
2. DECRESCE R. The CAS 100: a computerized microscope image analysis system. Lab Med 1986: 17: 163-5.
3. FIDLER IJ, ELLIS LM. The implication of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994: 79: 185-8.
4. FOLKMAN J. Tumor angiogenesis: therapeutic implication. New Engl J Med 1971: 285: 1182-6.
5. FOLKMAN J. What is the evidence that tumors are angiogenesis dependent. J Natl Cancer Inst 1990: 82: 4-6.
6. INGBER D, FUJITA T, KISHIMOTO S, et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 1990: 348: 555-7.
7. KAMEI S, OKADA H, INOUE Y, YOSHIOKA T, OGAWA Y, TOGUCHI H. Antitumor effects of angiogenesis inhibitor TNP-470 in rabbits bearing VX2 carcinoma by arterial administration of microspheres and oil solution. J Pharmacol Exp Ther 1993: 264: 469-74.
8. KERBEL RS. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents. BioEssays 1991: 13: 31-6.
9. KIM KJ, WINER J, ARMANINI M, GILLETT N, PHILLIP HS, FERRARA N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993: 362: 841-4.
10. KONNO H, TANAKA T, KANAI T, MARUYAMA K, NAKAMURA S, BABA S. Efficacy of an angiogenesis inhibitor, TNP-470, in xenotransplanted human colorectal cancer with high metastatic potential. Cancer 1996: 77: 1736-40.
11. LANGER R, FOLKMAN J. Polymers for the sustained release of proteins and other macromolecules. Nature 1976: 263: 797-800.
12. LIOTTA L, KLEINERMAN J, SAIDEL G. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastasis following tumor implantation. Cancer Res 1974: 34: 997-1004.
13. MACCHIARINI P, FONTANINI G, HARDIN MJ, SQUARTINI F, ANGELETTI CA. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 1992: 340: 145-6.
14. MAEDA K, CHUNG YS, TAKATSUKA S, et al. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 1995: 13: 477-81.
15. MILLAUER B, LONGHI MP, PLATE KH, et al. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res 1996: 56: 1615-20.
16. OHTA Y, WATANABE Y, TABATA T, et al. Inhibition of lymph node metastasis by an anti-angiogenic agent, TNP-470. Br J Cancer 1997: 75: 512-5.
17. PENFOLD CN, PATRIDGE M, ROJAS R, LANGDON JD. The role of angiogenesis in the spread of oral squamous cell carcinoma. Br J Oral Maxillofac Surg 1996: 34: 37-41.
18. SHISHIDO T, YASUHIRO T, DENNO R, SATO N, HIRATA K. Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470. Jpn J Cancer Res 1996: 87: 958-62.
19. TANAKA T, KONNO H, MATSUDA I, NAKAMURA S, BABA S. Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res 1995: 55: 836-9.
20. WEIDNER N, CARROL PR, FLAX J, BLUMENFELD W, FOLKMAN J. Tumor angiogenesis correlates with metastasis in invasive prostate cancer. Am J Pathol 1993: 143: 401-9.
21. WEIDNER N, SEMPLE JP, WELCH WR, FOLKMAN J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New Engl J Med 1991: 324: 1-8.
22. WILLIAMS JK, CARLSON GW, COHEN C, DEROSE PB, HUNTER S, JURKIEWICZ MJ. Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 1994: 168: 373-80.
23. YAMAOKA M, YAMAMOTO T, IKEYAMA S, SUDO K, FUJITA T. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res 1993: 53: 5233-6.
24. YAMAOKA M, YAMAMOTO T, MASAKI T, IKEYAMA S, SUDO K, FUJITA T. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor o-(chloroacetyl - carbamoyl) fumagillol (TNP-470: AGM-1470). Cancer Res 1993: 53: 4262-7.
25. YANASE T, TAMURA M, FUJITA K, KODAMA S, TANAKA K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 1993: 53: 2566-70.